President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.